When a fixed regulatory deadline meets withheld evidence and shifting interpretations, questions follow. This open letter examines how the UK Food Standards Agency has applied its CBD novel foods rules—and whether those decisions can be properly scrutinised.

It's time to whistleblow against the FSA on behalf of the Hemp and CBD industry, there is blatantly a level of corruption that needs to be e